Introduction

The COVID trial is investigating prostocyclin in mechanically ventilated patients infected with SARS-CoV-2 and with severe endothelialopathy. What if this intervention produces a quite startling effect in a blinded randomized controlled trial? Today I'm joined by Peria Hansen from Copenhagen, Denmark to discuss the intriguing study.